MERITAGE PORTFOLIO MANAGEMENT - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
MERITAGE PORTFOLIO MANAGEMENT ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$690
+23.2%
25,319
+0.6%
0.05%
+27.5%
Q2 2023$560
+32.1%
25,173
+28.5%
0.04%
+25.0%
Q1 2023$424
+6.3%
19,588
-0.4%
0.03%
+3.2%
Q4 2022$399
-99.9%
19,662
+3.2%
0.03%
-24.4%
Q3 2022$489,000
+11.6%
19,055
+3.4%
0.04%
+20.6%
Q2 2022$438,000
+3.1%
18,422
-2.4%
0.03%
+30.8%
Q1 2022$425,000
+104.3%
18,878
+79.8%
0.03%
+116.7%
Q4 2021$208,00010,5000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders